IAPAC mourns the passing of Canadian HIV researcher, Mark A. Wainberg, PhD, who identified lamivudine (3TC) as effective against HIV, fought HIV denialism, advocated global scale-up of antiretroviral therapy, and promoted the right of HIV-vulnerable people to live free of social intolerance. Click here to read IAPAC’s statement.